A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TD-1473 in Healthy Adult Japanese Subjects
Latest Information Update: 14 Mar 2019
Price :
$35 *
At a glance
- Drugs Izencitinib (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Theravance Biopharma
- 08 Mar 2019 Status changed from recruiting to completed.
- 26 Nov 2018 New trial record